结果:两组患者治疗前一般资料比较无差异(P>0.05),两组患者BCVA(0.63±0.13 vs 0.76±0.19; t=4.123,P<0.001)、CMT(305.89±58.76 vs 340.26±60.41μm; t=2.954,P=0.004)比较有差异,而两组患者眼压对比(12.11±1.82 vs 12.24±1.59mmHg; t=0.389,P=0.700)无差异; 观察组患者术后1mo视野灰度值、视野平均缺损值显著低于对照组(P<0.001); 观察组患者术后1mo 30°视野平均光阈值敏感度显著高于对照组(P<0.001)。
Objective To investigate the incidence of retinopathy of prematurity(ROP)in Dongguan People's Hospital. Methods Records of premature infants who had undergone ROP screening in our hospital between June 2009 and October 2010 were analyzed retrospectively. Results Twenty-one cases out of 126 screened infants had developed ROP. Both eyes suffered from ROP in all the cases. The incidence of ROP was 16.67%. Of 19 cases(15.08%)developed ROP less than prethreshold and 2 cases(1.59%)developed threshold ROP. Among the 126 screened infants, 13(31.71%)out of 41 premature infants with birth weight(BW)<1500g and 8(9.41%)out of 85 with 1500g≤BW<2000g developed ROP, 15(30.61%)out of 49 with gestational age (GA)<32W and 6(7.79%)out of 77 with GA≥ 32W developed ROP. The incidence of ROP either among the groups of BW<1500g andl500g≤BW<2000g(x2=9.899, P <0.01), or among the groups of GA<32W and GA≥32W(x2=11.227, P<0.01)had statistical differences. Conclusions The incidence of ROP is 16.67% in Dongguan People's Hospital in present study. The incidence of severe ROP is low. Birth weight and gestational age are important factors to affect ROP incidence. 相似文献
结果:随访12mo末,联合治疗组与单纯注药组BCVA(LogMAR)(0.44±0.22 vs 0.55±0.23)与CRT(335.3±65.9 vs 370.4±84.4μm)有差异(P<0.05)。联合治疗组的平均注药次数少于单纯注药组(4.04±1.08 vs 5.83±1.92次,t=-5.722,P<0.05)。两组患者眼压(13.87±2.55 vs 14.04±2.69mmHg)无差异(P>0.05)。